Ozonated Gel Phonophoresis On Chronic Lateral Epicondylitis
Epicondylitis
About this trial
This is an interventional treatment trial for Epicondylitis
Eligibility Criteria
Inclusion Criteria: All patients would be diagnosed as chronic lateral epicondylitis from both genders. Patients with chronic lateral epicondylitis that diagnosed by orthopedist. Positive clinical manifestation in all patients. Pain onset is more than 3 months. All participants must be medically stable and not be treated with analgesics or any medication which may cause misleading results. All patients had body mass index between 18.5 and 29.9 kg/m2. Exclusion Criteria: Subjects would be excluded if they have: Received intra articular injection from duration less than 3 months. Elbow instability. History of cancer. Pregnancy Infection. Skin diseases on elbow area. Open wound in elbow. Shoulder or elbow fractures Systemic diseases such as rheumatoid arthritis, Reiter's syndrome, or diabetes. Neurological diseases. Severe medical or psychiatric disorders. Elbow surgery. Entrapment of the radial nerve. Arthritis and effusion of the elbow.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Experimental group
Control group
this group of 20 subjects will receive the ozonated media phonophoresis plus conventional physical therapy program 3 times weekly for 4 weeks.
this group of 20 subjects will receive only conventional physical therapy program 3 times weekly for 4 weeks.